Children's Memorial Health Institute, Poland   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Warsaw Poland (1977)

Organization Overview

First Clinical Trial
2002
NCT00195988
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Children's Memorial Health Institute, Poland | Children's Memorial Health Institute, Warszawa, Poland | Children's Memorial Health Institute, Warzaw, Poland | Katarzyna Kotulska | Piotr Socha

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Constipation (Phase 4)

Crohn Disease (Phase 3)

Diarrhea (Phase 2)

Fatty Liver (Phase 2)

Gaucher Disease (Phase 3)

Liver Diseases (Phase 2)

Non-alcoholic Fatty Liver Disease (Phase 2)

Vitamin D Deficiency (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 16
  • # of Trial APIs: 21